How can we minimise the use of regular oral corticosteroids in asthma?

Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing interest since the 1970s because of the side-effects of OCSs, and this has now become achievable with biologics. The Société de Pneumologie de Langue Française workshop on OCSs aimed to conduct a comprehensive revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdin, Arnaud, Adcock, Ian, Berger, Patrick, Bonniaud, Philippe, Chanson, Philippe, Chenivesse, Cécile, de Blic, Jacques, Deschildre, Antoine, Devillier, Philippe, Devouassoux, Gilles, Didier, Alain, Garcia, Gilles, Magnan, Antoine, Martinat, Yan, Perez, Thierry, Roche, Nicolas, Taillé, Camille, Val, Pierre, Chanez, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488989/
https://www.ncbi.nlm.nih.gov/pubmed/32024721
http://dx.doi.org/10.1183/16000617.0085-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488989/
https://www.ncbi.nlm.nih.gov/pubmed/32024721
http://dx.doi.org/10.1183/16000617.0085-2019

Ejemplares similares